Obtaining blood samples for anti-factor Xa quantification through umbilical artery catheters

Journal of Perinatology

Volumn 22, Issue 6, 2002, Pages 475-477

  Edstrom, Cynthia S ^a   McBride, Jason ^a   Theriaque, Douglas ^b   Kao, K J ^a   Christensen, Robert D ^c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A; HEPARIN;

ANTICOAGULANT THERAPY; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CONTAMINATION; HUMAN; METHODOLOGY; NEWBORN; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; UMBILICAL ARTERY CATHETER; VEIN PUNCTURE; BLOOD; CENTRAL VENOUS CATHETERIZATION; EQUIPMENT; EQUIPMENT DESIGN; FEMALE; FIBRINOLYTIC THERAPY; INSTRUMENTATION; MALE; MONITORING; NEWBORN INTENSIVE CARE; PROBABILITY; SENSITIVITY AND SPECIFICITY; THROMBOSIS; UMBILICAL ARTERY;

CATHETERIZATION, CENTRAL VENOUS; EQUIPMENT DESIGN; EQUIPMENT SAFETY; FACTOR XA; FEMALE; HEPARIN; HUMAN; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MALE; MONITORING, PHYSIOLOGIC; PROBABILITY; SENSITIVITY AND SPECIFICITY; THROMBOLYTIC THERAPY; THROMBOSIS; UMBILICAL ARTERIES; HUMANS;

EID: 0036708240     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7210763     Document Type: Article

References (12)

1. Evaluation and treatment of thrombosis in the neonatal intensive care unit
2. Consistent approaches to procedures and practices in neonatal hematology
3. Heparin and low-molecular-weight heparin: Mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety
4. Effect of heparinization of fluids infused through an umbilical artery catheter on catheter patency and frequency of complications
5. Increased anticoagulation during cardiopulmonary bypass by prostaglandin E1
6. Anticoagulation with prostaglandin E1 and unfractionated heparin during continuous venovenous hemofiltration
7. Minimum discard volume from arterial catheters to obtain coagulation studies free of heparin effect
8. Comparison of coagulation test results for blood samples obtained by means of direct venipuncture and through a jugular vein catheter in clinically normal dogs
9. Relationship between arterial and venous activated partial thromboplastin time values in patients after percutaneous transluminal coronary angioplasty
10. Discard volumes necessary for clinically useful coagulation studies from heparinized Hickman catheters